Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Mar. 31, 2018
Current Assets:
Cash	$ 6,043,302	$ 4,381,643
Accounts receivable, net of allowance for doubtful accounts of $14,046 at December 31, 2018 and $23,046 at March 31, 2018	598,377	1,201,117
Due from related parties	25,558	14,204
Inventories, at lower cost or market, principally average cost method	3,951,308	2,405,007
Prepaid expenses	282,861	321,074
Total Current Assets	10,901,406	8,323,045
Equipment, net of accumulated depreciation of $341,330 at December 31, 2018 and $113,158 at March 31, 2018	2,642,987	1,241,326
Other Assets:
Deposits	55,415	16,300
Licensing agreements, net of accumulated amortization of $95,833 at December 31, 2018 and $58,333 at March 31, 2018	154,167	191,667
Patents, net of accumulated amortization of $113,433 at December 31, 2018 and $49,627 at March 31, 2018	8,559,733	900,373
TOTAL ASSETS	22,313,708	10,672,711
Current Liabilities:
Accounts payable	366,076	479,465
Accrued liabilities	474,797	541,210
Insurance premium note payable		99,907
Contingent consideration payable	1,200,000
Convertible promissory notes, net of $164,495 of note issuance costs	1,545,505
Total Current Liabilities	3,586,378	1,120,582
Shareholders' Equity:
Common stock, $0.001 par value, 200,000,000 shares authorized 34,610,586 and 28,394,503 shares issued and outstanding at December 31, 2018 and March 31, 2018, respectively	34,610	28,394
Additional paid-in capital	30,407,679	17,264,888
Accumulated (Deficit)	(11,714,959)	(7,741,153)
Total Shareholders' Equity	18,727,330	9,552,129
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 22,313,708	$ 10,672,711